• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于慢病毒载体的异种移植肿瘤作为检测HER2低表达乳腺癌的候选参考材料。

Lentiviral vector-based xenograft tumors as candidate reference materials for detection of HER2-low breast cancer.

作者信息

Wei Yali, An Xu, Cao Qinmei, Che Nanying, Xue Yuanyuan, Deng Haiteng, Wang Qingtao, Zhou Rui

机构信息

Department of Clinical Laboratory, Beijing Chaoyang Hospital, The Third Clinical Medical College of Capital Medical University, Beijing, China.

Department of Clinical Laboratory, Tongzhou Maternal and Child Health Hospital of Beijing, Beijing, China.

出版信息

Front Oncol. 2022 Aug 16;12:955943. doi: 10.3389/fonc.2022.955943. eCollection 2022.

DOI:10.3389/fonc.2022.955943
PMID:36052254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9425432/
Abstract

The human epidermal growth factor receptor 2 (HER2) is an important biomarker that plays a pivotal role in therapeutic decision-making for patients with breast cancer (BC). Patients with HER2-low BC can benefit from new HER2 targeted therapy. For ensuring the accurate and reproducible detection of HER2-low cancer, reliable reference materials are required for monitoring the sensitivity and specificity of detection assays. Herein, a lentiviral vector was used to transduce the HER2 gene into MDA-MB-231 cells that exhibited low HER2 density, and the cells were characterized by droplet digital PCR to accurately determine the copy number variation. Then, the formalin-fixed paraffin-embedded (FFPE) samples from xenografts were prepared and evaluated for suitability as candidate reference materials by immunohistochemistry (IHC) and fluorescence hybridization (FISH). The FFPE reference materials were selected on the basis of IHC score of 2+ and negative FISH result to meet the requirement for HER2-low BC detection. Furthermore, the FFPE reference materials exhibited typical histological structures that resembled the clinical BC specimens. These novel FFPE reference materials displayed the high stability and homogeneity, and they were produced in high quantity. In summary, we generated high-quality reference materials for internal quality control and proficiency testing in HER2-low detection.

摘要

人表皮生长因子受体2(HER2)是一种重要的生物标志物,在乳腺癌(BC)患者的治疗决策中起着关键作用。HER2低表达的BC患者可从新的HER2靶向治疗中获益。为确保准确、可重复地检测HER2低表达癌症,需要可靠的参考材料来监测检测方法的灵敏度和特异性。在此,使用慢病毒载体将HER2基因转导至HER2密度低的MDA-MB-231细胞中,并通过液滴数字PCR对细胞进行表征,以准确确定拷贝数变异。然后,制备来自异种移植瘤的福尔马林固定石蜡包埋(FFPE)样本,并通过免疫组织化学(IHC)和荧光杂交(FISH)评估其作为候选参考材料的适用性。根据IHC评分为2+且FISH结果为阴性来选择FFPE参考材料,以满足HER2低表达BC检测的要求。此外,FFPE参考材料呈现出与临床BC标本相似的典型组织结构。这些新型FFPE参考材料具有高稳定性和均一性,且产量高。总之,我们生成了用于HER2低表达检测内部质量控制和能力验证的高质量参考材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/b78d3cffd123/fonc-12-955943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/9ee2276066db/fonc-12-955943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/bf6f8f658463/fonc-12-955943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/a1f273740f4b/fonc-12-955943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/753e8459fc56/fonc-12-955943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/5d849d296526/fonc-12-955943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/b78d3cffd123/fonc-12-955943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/9ee2276066db/fonc-12-955943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/bf6f8f658463/fonc-12-955943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/a1f273740f4b/fonc-12-955943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/753e8459fc56/fonc-12-955943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/5d849d296526/fonc-12-955943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1152/9425432/b78d3cffd123/fonc-12-955943-g006.jpg

相似文献

1
Lentiviral vector-based xenograft tumors as candidate reference materials for detection of HER2-low breast cancer.基于慢病毒载体的异种移植肿瘤作为检测HER2低表达乳腺癌的候选参考材料。
Front Oncol. 2022 Aug 16;12:955943. doi: 10.3389/fonc.2022.955943. eCollection 2022.
2
Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer.细胞系作为乳腺癌中ERBB2扩增和表达检测质量控制的候选参考物质。
Clin Chem. 2009 Jul;55(7):1307-15. doi: 10.1373/clinchem.2008.120576. Epub 2009 May 14.
3
Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.福尔马林固定石蜡包埋的乳腺癌和胃癌样本中HER2扩增的液滴数字聚合酶链反应检测
Exp Mol Pathol. 2016 Apr;100(2):287-93. doi: 10.1016/j.yexmp.2015.11.027. Epub 2015 Nov 25.
4
CRISPR/Cas9 Technology-Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing.基于CRISPR/Cas9技术的异种移植肿瘤作为多种EML4-ALK重排检测的候选参考材料
J Mol Diagn. 2017 Sep;19(5):766-775. doi: 10.1016/j.jmoldx.2017.06.003. Epub 2017 Jul 18.
5
Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.通过液滴数字聚合酶链反应检测福尔马林固定石蜡包埋的乳腺癌和胃癌样本中的人表皮生长因子受体2扩增
J Cancer Res Ther. 2017;13(4):730-734. doi: 10.4103/jcrt.JCRT_587_17.
6
Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.一种基于实时定量聚合酶链反应(RT-qPCR)的新型检测方法用于乳腺癌中HER2基因表达定量的开发与评估。
Gene. 2017 Mar 20;605:114-122. doi: 10.1016/j.gene.2016.12.027. Epub 2016 Dec 28.
7
Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.采用两种 TFF3 序列作为内参的数字 PCR 检测福尔马林固定石蜡包埋乳腺癌组织中的 HER2 扩增。
Exp Mol Pathol. 2018 Jun;104(3):235-238. doi: 10.1016/j.yexmp.2018.04.004. Epub 2018 Apr 30.
8
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.一种用于人表皮生长因子受体 2(HER2)的基因-蛋白检测方法:在福尔马林固定、石蜡包埋的乳腺癌组织切片中,对 HER2 蛋白、HER2 基因和 17 号染色体着丝粒(CEN17)进行明场三色可视化。
Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.
9
Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection.用于人类表皮生长因子受体2状态检测质量控制的候选参考样本类型比较。
Diagn Pathol. 2016 Sep 10;11(1):85. doi: 10.1186/s13000-016-0537-8.
10
Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue.液滴数字 PCR 检测福尔马林固定石蜡包埋乳腺癌组织中 HER2 拷贝数改变。
Clin Chem. 2013 Jun;59(6):991-4. doi: 10.1373/clinchem.2012.197855. Epub 2013 Jan 28.

本文引用的文献

1
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience.HER2低表达早期乳腺癌的临床病理特征及预后:单机构经验
Front Oncol. 2022 Jun 16;12:906011. doi: 10.3389/fonc.2022.906011. eCollection 2022.
2
Targeting HER2 heterogeneity in breast cancer.针对乳腺癌中的 HER2 异质性。
Cancer Treat Rev. 2021 Nov;100:102286. doi: 10.1016/j.ctrv.2021.102286. Epub 2021 Sep 2.
3
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
HER2 低表达阳性乳腺癌的临床和分子特征:四项前瞻性新辅助临床试验中个体患者数据的汇总分析。
Lancet Oncol. 2021 Aug;22(8):1151-1161. doi: 10.1016/S1470-2045(21)00301-6. Epub 2021 Jul 9.
4
HER2: a never ending story.人表皮生长因子受体2:一个永无止境的故事。
Lancet Oncol. 2021 Aug;22(8):1051-1052. doi: 10.1016/S1470-2045(21)00349-1. Epub 2021 Jul 9.
5
Development of novel quality control material based on CRISPR/Cas9 editing and xenografts for MLH1 protein deficiency testing.基于 CRISPR/Cas9 编辑和异种移植的新型质量控制材料的开发,用于 MLH1 蛋白缺陷检测。
J Clin Lab Anal. 2021 May;35(5):e23746. doi: 10.1002/jcla.23746. Epub 2021 Apr 7.
6
HER2 fluorescent in situ hybridization signal degradation: a 10-year retrospective study.HER2 荧光原位杂交信号降解:一项 10 年回顾性研究。
Breast Cancer Res Treat. 2021 Feb;186(1):99-105. doi: 10.1007/s10549-020-06048-9. Epub 2021 Jan 3.
7
Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges.慢病毒载体的大规模生产:当前观点与挑战
Pharmaceutics. 2020 Nov 3;12(11):1051. doi: 10.3390/pharmaceutics12111051.
8
Frequent Tumor Burden Monitoring of Esophageal Squamous Cell Carcinoma With Circulating Tumor DNA Using Individually Designed Digital Polymerase Chain Reaction.使用个体化设计的数字聚合酶链反应通过循环肿瘤DNA对食管鳞状细胞癌进行频繁的肿瘤负荷监测
Gastroenterology. 2021 Jan;160(1):463-465.e4. doi: 10.1053/j.gastro.2020.09.035. Epub 2020 Oct 2.
9
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020.《数字 MIQE 指南更新:2020 年定量数字 PCR 实验发表的最低信息要求》。
Clin Chem. 2020 Aug 1;66(8):1012-1029. doi: 10.1093/clinchem/hvaa125.
10
ARX788, a Site-specific Anti-HER2 Antibody-Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1-resistant Breast and Gastric Cancers.ARX788,一种靶向 HER2 的抗体药物偶联物,在 HER2 低表达和 T-DM1 耐药的乳腺癌和胃癌中显示出强大和选择性的活性。
Mol Cancer Ther. 2020 Sep;19(9):1833-1843. doi: 10.1158/1535-7163.MCT-19-1004. Epub 2020 Jul 15.